Citation:Kurtkaya-Yapicier O, Gencosmanoglu R, Avsar E, Bakirci N, Tozun N, Sav A 2003

From Cancer Guidelines Wiki

Citation


Kurtkaya-Yapicier O, Gencosmanoglu R, Avsar E, Bakirci N, Tozun N, Sav A. The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable? BMC Clin Pathol 2003 Dec 2;3(1):5 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/14651756.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Are there biomarkers for the diagnosis (presence) of BO?Professor Reginald V Lord MBBS MD FRACScompleted
Are there biomarkers for the diagnosis (presence) of BO?Angelique Levertpending

Compare quality appraisals for each clinical question

Cited by

  1. Are there biomarkers for the diagnosis (presence) of BO?
  2. Are there biomarkers for the diagnosis (presence) of BO?/Appendix Body of evidence assessment